Outcome of heart failure with preserved ejection fraction in a population-based study.
By R. Bhatia, Jack V. Tu, Douglas S. Lee, Peter C. Austin, Jiming Fang, A. Haouzi, Y. Gong, Peter P. Liu. New England Journal of Medicine, 2006
1,832 citations recorded by the source corpus.
Subfields: Cardiology and Cardiovascular Medicine, Surgery
View Paper: https://www.semanticscholar.org/paper/8623f426f8d980af6796f1d1c0f581221d63b382
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Cardiology and Cardiovascular Medicine
- G. Fonarow
- T. Horwich
- E. Potter
- C. Herrmann-Lingen
- Rong Tian
- T. Marwick
- E. Dale Abel
- Ramachandran S. Vasan
In Surgery
Citations in the corpus
- Relation of Disease Pathogenesis and Risk Factors to Heart Failure With Preserved or Reduced Ejection Fraction: Insights From the Framingham Heart Study of the National Heart, Lung, and Blood Institute (2009, neutral): “LBBB, n (%) 31 (11) 9 (21) 33 (24) 10 (14) 0.”
- Heart Failure With Preserved, Borderline, and Reduced Ejection Fraction: 5-Year Outcomes. (2017, result): “Previous studies have shown conflicting data with respect to survival in patients with HFpEF compared with HFrEF (4,5,7,9,11,17).”
- Cardiorenal syndrome. (2008, neutral): “(55).”
- Systolic blood pressure at admission, clinical characteristics, and outcomes in patients hospitalized with acute heart failure. (2006, neutral): “At discharge 63 (11) 66 (12) 68 (13) 71 (14)”
- Epidemiology of heart failure with preserved ejection fraction (2017, neutral): “Bhatia et al.(40) 1999–2001 Ontario, Canada >50 31 (880/2,802)”
- Epidemiology and clinical course of heart failure with preserved ejection fraction (2011, background): “5%.(24,25) The long-term mortality rates seem more variable in the reported”
- Impact of Non-Cardiac Comorbidities on Morbidity and Mortality in a Predominantly Male Population with Heart Failure and Preserved versus Reduced Ejection Fraction (2012, background): “In addition, studies have also shown that although the clinical signs and symptoms of HF are similar between HFpEF and HFrEF, patients with HFpEF are less likely to receive diuretic agents for congestion, anticoagulation therapy for atrial fibrillation, smoking cessation counseling, complete dischar”
- 2013 ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. (2013, background): “In April 2011, the Institute of Medicine released 2 reports: Clinical Practice Guidelines We Can Trust and Finding What Works in Health Care: Standards for Systematic Reviews (2, 3).”